Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Semaglutide prescribed specifically for weight loss is marketed under the brand name Wegovy; when prescribed off-label for diabetes, it is called Ozempic. Both contain the same active compound—a GLP-1 receptor agonist originally developed for type 2 diabetes that increases satiety and slows gastric emptying, reducing caloric intake by an average of 10–15% in clinical studies.
Understanding the differences between branded semaglutide formulations and available alternatives is essential for patients exploring treatment options. PlexusDx emphasizes precision wellness by helping you evaluate not only medication names and cost, but also genetic predispositions in peptide pathways and clinical indicators that may influence how your body responds to semaglutide therapy.
Branded Semaglutide Names and FDA Approval Status
Wegovy is the FDA-approved branded semaglutide injection formulated specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. Ozempic, also FDA-approved by Novo Nordisk, is indicated for type 2 diabetes but is frequently prescribed off-label for weight loss due to clinical efficacy data and patient demand.
A third option, Rybelsus, is an oral semaglutide tablet approved for diabetes management. Off-label oral semaglutide use for weight loss has gained clinical interest, though branded oral options remain limited. Both branded and compounded formulations exist in the current market, each with different regulatory pathways and cost implications.
Branded vs. Compounded Semaglutide: What Patients Should Know
Branded semaglutide (Wegovy, Ozempic) undergoes FDA manufacturing oversight and standardized dosing protocols. Compounded semaglutide is prepared by licensed 503A compounding pharmacies and tailored to individual patient needs, often at lower out-of-pocket cost. Both routes require a valid prescription and ongoing provider supervision.
| Characteristic |
Branded Semaglutide |
Compounded Semaglutide |
| Regulatory pathway |
FDA-approved, mass-manufactured |
Licensed 503A compounding pharmacy |
| Typical monthly cost |
$900–$1,400+ |
$179–$229 |
| Dose customization |
Fixed strength options |
Tailored dosing per provider |
| Availability |
Pharmacy supply-dependent |
Often more accessible |
| Clinical oversight |
Standard protocol |
Individualized provider-guided |
How Genetic Predispositions Inform Semaglutide Selection
Genetic variation in GLP-1 receptor pathways, FTO gene expression, and MC4R signaling can influence individual weight metabolism and potential response patterns to semaglutide. Specific variants (GLP1R rs6923761, FTO rs9939609, MC4R rs17782313) may provide context about metabolic predispositions and appetite regulation capacity in peptide-responsive pathways.
PlexusDx's Precision Peptide Genetic Test reveals predispositions in these pathways, which may help provide context for provider discussions about medication selection and expected response timelines. These insights do not predict exact medication response but can support a more personalized conversation with your healthcare provider about whether semaglutide aligns with your genetic metabolic profile.
Medical Eligibility, Safety Considerations, and Provider Guidance
Semaglutide is indicated for adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related conditions (hypertension, type 2 diabetes, cardiovascular disease). Contraindications include personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2. Pregnancy is contraindicated; discontinuation is recommended before conception.
Common side effects include nausea, vomiting, constipation, and abdominal discomfort, typically mild and transient. Serious but rare risks include pancreatitis and gallbladder disease. A qualified healthcare provider should evaluate your medical history, current medications, and treatment goals before initiating semaglutide therapy. Regular follow-up monitoring ensures safety and optimal dosing.
How PlexusDx Supports a More Personalized Approach
PlexusDx offers compounded semaglutide injections ($179–$229/month) and oral semaglutide formulations ($209/month) prepared by licensed 503A compounding pharmacies, providing accessible alternatives to branded options while maintaining clinical standards and provider oversight. These compounded formulations may help provide cost-effective precision wellness support when evaluated alongside your genetic and clinical profile.
The Precision Peptide Genetic Test ($99 add-on, $298 standalone) examines key variants in GLP1R, GIPR, FTO, and MC4R genes that reflect predispositions in peptide metabolic pathways. Understanding these pathways may help inform whether GLP-1 agonist therapy aligns with your metabolic genetics, though genetic predisposition does not guarantee exact medication response and should be interpreted with your qualified healthcare provider.
Combining genetic insights with cost-effective compounded medication access and structured provider communication may support a more informed, personalized treatment decision. Discuss your genetic test results and medication options with your provider to develop a weight management strategy tailored to your unique clinical and genetic context.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at from $209/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Happens If You Miss a Week of Tirzepatide? | PlexusDx
Hiccups as a Semaglutide Side Effect: Clinical Context